a significant trendp = 0.07
However, Nikolouzakis et al., studying TA in PBLs from 28 patients with mCRC, described that TA presented a significant trend of increase ( p = 0.07) in patients with progressive disease at the middle of their treatment when compared with that before the initiation [ 27 ].